EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools

Ilaria Cela, Emily Capone, Gianluca Trevisi, Gianluca Sala

Seminars in Cancer Biology · 2024

DOI: 10.1016/j.semcancer.2024.04.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2024. Verfasst von Ilaria Cela und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Innovative Technologies in Medicine & Dentistry, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy; Center for Advanced Studi…. Hauptthemen laut MEDLINE: Glioblastoma, Extracellular Vesicles, Biomarkers, Tumor, Brain Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most aggressive tumor among the gliomas and intracranial tumors and to date prognosis for GBM patients remains poor, with a median survival typically measured in months to a few years depending on various factors. Although standardized therapies are routinely employed, it is clear that these strategies are unable to cope with heterogeneity and invasiveness of GBM. Furthermore, diagnosis and monitoring of responses to therapies are directly dependent on tissue biopsies or magnetic resonance imaging (MRI) techniques. From this point of view, liquid biopsies are arising as key sources of a variety of biomarkers with the advantage of being easily accessible and monitorable. In this context, extracellular vesicles (EVs), physiologically shed into body fluids by virtually all cells, are gaining increasing interest both as natural carriers of biomarkers and as specific signatures even for GBM. What makes these vesicles particularly attractive is they are also emerging as therapeutical vehicles to treat GBM given their native ability to cross the blood-brain barrier (BBB). Here, we reviewed recent advances on the use of EVs as biomarker for liquid biopsy and nanocarriers for targeted delivery of anticancer drugs in glioblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaExtracellular VesiclesBiomarkers, TumorBrain NeoplasmsHumansAnimalsLiquid BiopsyBlood-Brain BarrierAntineoplastic Agents

Stichwörter der Autor:innen

Extracellular vesiclesGlioblastomaLiquid biopsyTargeted therapy

Substanzen

Biomarkers, TumorAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Innovative Technologies in Medicine & Dentistry, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy; Center for Advanced Studies and Technology (CAST), University "G. D'Annunzio" of Chieti-Pescara…
  • Department of Neurosciences, Imaging and Clinical Sciences, "G. D'Annunzio" University, Chieti, Italy; Neurosurgical Unit, Santo Spirito Hospital, Pescara 65121, Italy.

Zitieren

APA

Cela, I., Capone, E., Trevisi, G., & Sala, G. (2024). Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2024.04.003

Vancouver

Cela I, Capone E, Trevisi G, Sala G. Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools. Seminars in Cancer Biology. 2024. doi:10.1016/j.semcancer.2024.04.003

BibTeX
@article{Cela2024,
  author = {Cela, Ilaria and Capone, Emily and Trevisi, Gianluca and Sala, Gianluca},
  title = {Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools},
  journal = {Seminars in Cancer Biology},
  year = {2024},
  doi = {10.1016/j.semcancer.2024.04.003}
}
Kostenlos starten →